Individualization of thiopurine therapy: thiopurine S-methyltransferase and beyond.

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Pharmacogenomics (London)

• Publication date

  2009-08-10

• Fields of study

  Medicine

• Identifiers
  DOI 10.2217/pgs.09.78PMID 19663675
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The Increasing Complexity of Mercaptopurine Pharmacogenomics

  2009cited by this paper
• Genetic Polymorphism of Inosine Triphosphate Pyrophosphatase Is a Determinant of Mercaptopurine Metabolism and Toxicity During Treatment for Acute Lymphoblastic Leukemia

  2009cited by this paper
• Heterozygosity at the TPMT gene locus, augmented by mutated MTHFR gene, predisposes to 6-MP related toxicities in childhood ALL patients

  2009cited by this paper
• S-adenosylmethionine regulates thiopurine methyltransferase activity and decreases 6-mercaptopurine cytotoxicity in MOLT lymphoblasts.

  2009cited by this paper
• Thiopurine S-methyltransferase genotype-phenotype concordance: used as a quality assurance tool to help control the phenotype assay

  2009cited by this paper
• Trinucleotide repeat variants in the promoter of the thiopurine S-methyltransferase gene of patients exhibiting ultra-high enzyme activity

  2008cited by this paper
• Serum Folate and Methylenetetrahydrofolate Reductase (MTHFR) C677T Polymorphism Adjusted for Folate Intake

  2008cited by this paper
• S-adenosylmethionine and its products

  2008cited by this paper
• Ethnic variation of thiopurine S-methyltransferase activity: a large, prospective population study.

  2008cited by this paper
• Functional characterization of 23 allelic variants of thiopurine S-methyltransferase gene (TPMT*2 – *24)

  2008cited by this paper
• Influence of xanthine oxidase on thiopurine metabolism in Crohn’s disease

  2008cited by this paper
• Thiopurine S-methyltransferase (TPMT) pharmacogenetics: three new mutations and haplotype analysis in the Estonian population

  2008cited by this paper
• Folate restriction and methylenetetrahydrofolate reductase 677T polymorphism decreases adoMet synthesis via folate-dependent remethylation in human-transformed lymphoblasts

  2007cited by this paper
• Using HapMap Tools in Pharmacogenomic Discovery: The Thiopurine Methyltransferase Polymorphism

  2007cited by this paper
• Associations of common polymorphisms in the thymidylate synthase, reduced folate carrier and 5-aminoimidazole-4-carboxamide ribonucleotide transformylase/inosine monophosphate cyclohydrolase genes with folate and homocysteine levels and venous thrombosis risk

  2007cited by this paper
• 'Drug reactions, enzymes, and biochemical genetics': 50 years later.

  2007cited by this paper
• Thiopurine Methyltransferase Activity in Spain: A Study of 14,545 Patients

  2007cited by this paper
• Differential effects of targeted disruption of thiopurine methyltransferase on mercaptopurine and thioguanine pharmacodynamics.

  2007cited by this paper
• Should TPMT genotype and activity be used to monitor 6‐mercaptopurine treatment in children with acute lymphoblastic leukaemia?

  2007cited by this paper
• Primum non nocere: adverse drug events must be taken seriously.

  2007cited by this paper
• Purine and folate metabolism as a potential target of sex-specific nutrient allocation in Drosophila and its implication for lifespan-reproduction tradeoff.

  2006cited by this paper
• Thiopurine S-Methyltransferase Pharmacogenetics: Genotype to Phenotype Correlation in the Slovenian Population

  2006cited by this paper
• Homocysteine, vitamin B12 and folate levels in premature coronary artery disease

  2006cited by this paper
• Human thiopurine S-methyltransferase pharmacogenetics: variant allozyme misfolding and aggresome formation.

  2005cited by this paper
• Folate pathway gene expression differs in subtypes of acute lymphoblastic leukemia and influences methotrexate pharmacodynamics.

  2005cited by this paper
• Thiopurine methyltransferase (TPMT) genotype and early treatment response to mercaptopurine in childhood acute lymphoblastic leukemia.

  2005cited by this paper
• Genetic variation in the MTHFR gene influences thiopurine methyltransferase activity.

  2005cited by this paper
• Phenotype and genotype for thiopurine methyltransferase activity in the French Caucasian population: impact of age

  2004cited by this paper
• Identification of factors regulating thiopurine methyltransferase activity in a Norwegian population

  2004cited by this paper
• A mathematical model of the methionine cycle.

  2004cited by this paper
• Pharmacogenetics of outcome in children with acute lymphoblastic leukemia.

  2004cited by this paper
• Cigarette smoke extract increases S-adenosylmethionine and cystathionine in human lung epithelial-like (A549) cells.

  2004cited by this paper
• Thiopurine methyltransferase: should it be measured before commencing thiopurine drug therapy?

  2004cited by this paper
• Consequences of binding an S-adenosylmethionine analogue on the structure and dynamics of the thiopurine methyltransferase protein backbone.

  2004cited by this paper
• Pharmacogenetics of Thiopurine S-Methyltransferase and Thiopurine Therapy

  2004cited by this paper
• Comprehensive analysis of thiopurine S-methyltransferase phenotype-genotype correlation in a large population of German-Caucasians and identification of novel TPMT variants.

  2004cited by this paper
• Activity Gene Abolishes USF-1 Binding and Alters Transcriptional Thymidylate Synthase Tandem Repeat Polymorphism of the ′ A Novel Single Nucleotide Polymorphism within the 5

  2003cited by this paper
• Thiopurine methyltransferase phenotypes and genotypes in Brazilians.

  2003cited by this paper
• Genotype and haplotype distributions of MTHFR 677C>T and 1298A>C single nucleotide polymorphisms: a meta-analysis

  2003cited by this paper
• Common variant in betaine‐homocysteine methyltransferase (BHMT) and risk for spina bifida

  2003cited by this paper
• Genetic polymorphism of thiopurine S-methyltransferase in Argentina

  2003cited by this paper
• Investigations of a common genetic variant in betaine-homocysteine methyltransferase (BHMT) in coronary artery disease.

  2003cited by this paper
• Phenotypic and Genotypic Analysis of Thiopurine S‐Methyltransferase Polymorphism in the Bulgarian Population

  2003cited by this paper
• Homocysteine‐betaine interactions in a murine model of 5,10‐methylenetetrahydrofolate reductase deficiency

  2003cited by this paper
• S-Adenosyl-L-methionine (SAMe): from the bench to the bedside--molecular basis of a pleiotrophic molecule.

  2002cited by this paper
• Shaw GM, Lammer EJ, Huiping Z, Wang Baker M, Neri E, Finnell RH. 2002. Maternal preconceptual vitamin use, genetic variation of infant reduced folate carrier (A80G), and risk of spina bifida. Am J Med Genet 108:1–6.

  2002cited by this paper
• A common mutation in the 5,10-methylenetetrahydrofolate reductase gene affects genomic DNA methylation through an interaction with folate status

  2002cited by this paper
• A stereospecific colorimetric assay for (S,S)-adenosylmethionine quantification based on thiopurine methyltransferase-catalyzed thiol methylation.

  2002cited by this paper
• Polymorphism of the thymidylate synthase gene and outcome of acute lymphoblastic leukaemia.

  2002cited by this paper
• Spontaneous oxidative stress and liver tumors in mice lacking methionine adenosyltransferase 1A

  2002cited by this paper
• Thiopurine methyltransferase phenotype and genotype in relation to azathioprine therapy in autoimmune hepatitis.

  2002cited by this paper
• Thymidylate synthase: a novel genetic determinant of plasma homocysteine and folate levels

  2002cited by this paper
• Molecular beacons for detecting DNA binding proteins

  2002cited by this paper
• Maternal periconceptional vitamin use, genetic variation of infant reduced folate carrier (A80G), and risk of spina bifida.

  2002cited by this paper
• Determinants of plasma total homocysteine concentration in the Framingham Offspring cohort.

  2001cited by this paper
• Preponderance of thiopurine S-methyltransferase deficiency and heterozygosity among patients intolerant to mercaptopurine or azathioprine.

  2001cited by this paper
• Genotype–phenotype correlation for thiopurine S-methyltransferase in healthy Italian subjects

  2001cited by this paper
• Mice deficient in methylenetetrahydrofolate reductase exhibit hyperhomocysteinemia and decreased methylation capacity, with neuropathology and aortic lipid deposition.

  2001cited by this paper
• Detection of one single mutation predicts thiopurine S‐methyltransferase activity in a population of Saami in northern Norway

  2001cited by this paper
• Influence of the variable number of tandem repeats located in the promoter region of the thiopurine methyltransferase gene on enzymatic activity

  2001cited by this paper
• Methionine adenosyltransferase 1A knockout mice are predisposed to liver injury and exhibit increased expression of genes involved in proliferation

  2001cited by this paper
• Childhood acute lymphoblastic leukaemia--current status and future perspectives.

  2001cited by this paper
• Genetic polymorphism of thiopurine methyltransferase and its clinical relevance for childhood acute lymphoblastic leukemia

  2000cited by this paper
• The quantitatively important relationship between homocysteine metabolism and glutathione synthesis by the transsulfuration pathway and its regulation by redox changes.

  2000cited by this paper
• Neonatal and fetal methylenetetrahydrofolate reductase genetic polymorphisms: an examination of C677T and A1298C mutations.

  2000cited by this paper
• Betaine-homocysteine methyltransferase-2: cDNA cloning, gene sequence, physical mapping, and expression of the human and mouse genes.

  2000cited by this paper
• 5,10-Methylenetetrahydrofolate reductase gene variants and congenital anomalies: a HuGE review.

  2000cited by this paper
• Homocysteine, folate, methylation, and monoamine metabolism in depression

  2000cited by this paper
• The frequency and distribution of thiopurine methyltransferase alleles in Caucasian and Asian populations.

  1999cited by this paper
• Polymorphism of the thiopurine S-methyltransferase gene in African-Americans.

  1999cited by this paper
• Mercaptopurine therapy intolerance and heterozygosity at the thiopurine S-methyltransferase gene locus.

  1999cited by this paper
• Analysis of thiopurine methyltransferase variant alleles in childhood acute lymphoblastic leukaemia

  1999cited by this paper
• Interaction between Dietary Methionine and Methyl Donor Intake on Rat Liver Betaine-homocysteine Methyltransferase Gene Expression and Organization of the Human Gene*

  1999cited by this paper
• A second common mutation in the methylenetetrahydrofolate reductase gene: an additional risk factor for neural-tube defects?

  1998cited by this paper
• Genotypic and phenotypic analysis of the polymorphic thiopurine S‐methyltransferase gene (TPMT) in a European population

  1998cited by this paper
• A common mutation in the methylenetetrahydrofolate reductase gene is associated with an accumulation of formylated tetrahydrofolates in red blood cells.

  1998cited by this paper
• Major lifestyle determinants of plasma total homocysteine distribution: the Hordaland Homocysteine Study.

  1998cited by this paper
• Acute lymphoblastic leukemia.

  1998cited by this paper
• Enhanced proteolysis of thiopurine S-methyltransferase (TPMT) encoded by mutant alleles in humans (TPMT*3A, TPMT*2): mechanisms for the genetic polymorphism of TPMT activity.

  1997cited by this paper
• Human thiopurine methyltransferase pharmacogenetics: Gene sequence polymorphisms

  1997cited by this paper
• Molecular Diagnosis of Thiopurine S-Methyltransferase Deficiency: Genetic Basis for Azathioprine and Mercaptopurine Intolerance

  1997cited by this paper
• S‐Adenosylmetliionine and methylation

  1996cited by this paper
• Relation between folate status, a common mutation in methylenetetrahydrofolate reductase, and plasma homocysteine concentrations.

  1996cited by this paper
• Functional analysis and DNA polymorphism of the tandemly repeated sequences in the 5'-terminal regulatory region of the human gene for thymidylate synthase.

  1995cited by this paper
• Fast and slow methylators: do racial differences influence risk of allograft rejections?

  1993cited by this paper
• Fast and slow methylators: do racial differences influence risk of allograft rejection?

  1993cited by this paper
• Importance of 6-mercaptopurine dose in lymphoblastic leukaemia.

  1991cited by this paper
• Structural and functional analysis of the human thymidylate synthase gene.

  1990cited by this paper
• Childhood lymphoblastic leukaemia: sex difference in 6-mercaptopurine utilization.

  1984cited by this paper

• Detailed resume of S-methyltransferases: Categories, structures, biological functions and research advancements in related pathophysiology and pharmacotherapy.

  2024cites this paper
• TPMT Genetic Variability and Its Association with Hematotoxicity in Indonesian Children with Acute Lymphoblastic Leukemia in Maintenance Therapy

  2021cites this paper
• PGPM_A_288988 199..210

  2021cites this paper
• Pharmacogenetic evaluation of 6-mercaptopurine-mediated toxicity in pediatric acute lymphoblastic leukemia patients from a South Indian population.

  2021cites this paper
• Methods for Determination of Reactive Metabolites of Thiopurines

  2020cites this paper
• Characterization of 6-Mercaptopurine Transport by the SLC43A3-Encoded Nucleobase Transporter

  2019cites this paper
• Points-to-consider documents: Scientific information on the evaluation of genetic polymorphisms during non-clinical studies and phase I clinical trials in the Japanese population.

  2018cites this paper
• Influence of thiopurine S‐methyltransferase polymorphisms in mercaptopurine pharmacokinetics in healthy volunteers

  2018cites this paper
• Thiopurine methyltransferase activity in children with acute myeloid leukemia.

  2018cites this paper
• Genomewide Approach Validates Thiopurine Methyltransferase Activity Is a Monogenic Pharmacogenomic Trait

  2017cites this paper
• In-depth analysis of factors affecting variability in thiopurine methyltransferase activity

  2017cites this paper
• Risk factors for symptomatic osteonecrosis in childhood ALL: A retrospective study of a Slovenian pediatric ALL population between 1970 and 2004.

  2016cites this paper
• Optimising the use of Azathioprine in the treatment of Inflammatory Bowel Disease

  2016cites this paper
• PACSIN2 polymorphism is associated with thiopurine-induced hematological toxicity in children with acute lymphoblastic leukaemia undergoing maintenance therapy

  2016cites this paper
• Roles Biomarkers in Basic and Clinical Research for Breast Cancer

  2015cites this paper
• Concepts of Anticancer Treatment and Pharmacogenomics in Cancer Treatments

  2015cites this paper
• A Pharmacokinetic Analysis and Pharmacogenomic Study of 6-mercaptopurine

  2015cites this paper
• Association of ITPA Genotype with Event-Free Survival and Relapse Rates in Children with Acute Lymphoblastic Leukemia Undergoing Maintenance Therapy

  2014cites this paper
• From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity.

  2014cites this paper
• Thiopurine S-Methyltransferase Phenotype and Genotype in Pediatric Patients with Inflammatory Bowel Disease; Implication for AzathioprineTreatment

  2013influential citation
• LOODUS- JA TEHNOLOOGIATEADUSKOND MOLEKULAAR- JA RAKUBIOLOOGIA INSTITUUT BIOTEHNOLOOGIA ÕPPETOOL

  2013cites this paper
• Validation of a genotyping method for analysis of TPMT polymorphisms.

  2012cites this paper
• Thiopurine S-methyltransferase phenotype-genotype correlation in children with acute lymphoblastic leukemia.

  2012cites this paper
• Post-translational stabilization of thiopurine S-methyltransferase by S-adenosyl-L-methionine reveals regulation of TPMT*1 and *3C allozymes.

  2012cites this paper
• Pharmacogenomics of chemotherapeutic susceptibility and toxicity

  2012cites this paper
• Using Germline Genomics to Individualize Pediatric Cancer Treatments

  2012cites this paper
• The Development, Validation and Implementation of a Broad-Based ADME Genotyping Assay into Research and Clinical Trials

  2012cites this paper
• Getting to the heart of the matter.

  2012cites this paper
• Roadmap to personalized medicine

  2012cites this paper
• S-Adenosylmethionine: A Novel Factor in the Individualization of Thiopurine Therapy

  2012cites this paper
• The pharmacogenetic basis of individual variation in thiopurine metabolism.

  2012cites this paper
• Drug‐Metabolising Enzymes: Genetic Polymorphisms

  2011cites this paper
• Clinically relevant genetic variations in drug metabolizing enzymes.

  2011cites this paper
• The pattern of gene expression and gene dose profiles of 6-Mercaptopurine- and 6-Thioguanine-resistant human leukemia cells.

  2011influential citation
• Pharmacogenomic biomarkers: new tools in current and future drug therapy.

  2011cites this paper
• Clinical Utility of Serological Markers and Thiopurine Drug Monitoring in IBD: An Evidence-Based Review

  2011cites this paper
• Association Between Adverse Effects Under Azathioprine Therapy and Inosine Triphosphate Pyrophosphatase Activity in Patients With Chronic Inflammatory Bowel Disease

  2011cites this paper
• The discovery of human genetic variations and their use as disease markers: past, present and future

  2010cites this paper
• Toward the development of innovative bifunctional agents to induce differentiation and to promote apoptosis in leukemia: clinical candidates and perspectives.

  2010cites this paper
• MTHFR and TYMS genotypes influence TPMT activity and its differential modulation in males and females.

  2010cites this paper
• Pharmacogenetics of thiopurine therapy: from thiopurine S-methyltransferase to S-adenosylmethionine

  2009cites this paper